North Huachuang Technology Group Co., Ltd.
Eighth Board of Directors Independent Director 2025 Annual Performance Report (Liu Yi)
To all shareholders and shareholder representatives:
As an independent director of North Huachuang Technology Group Co., Ltd. (hereinafter referred to as the "Company") for the Eighth Board of Directors, I have strictly followed the "Company Law of the People's Republic of China," the "Management Measures for Independent Directors of Listed Companies," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 1 - Normative Operation of Main Board Listed Companies," and other relevant laws, regulations, and the "Articles of Association" and "Independent Director Work System" during 2025. I have diligently and faithfully performed my duties, attended board meetings, relevant special committee meetings, independent director special meetings, and shareholder meetings convened by the Company in 2025. I have carefully reviewed the proposals and materials for each meeting and made independent judgments, expressed opinions on significant matters, and effectively protected the legitimate rights and interests of the Company and its shareholders, especially minority shareholders. The performance report for this year is as follows:
I. Basic Information
(I) Personal Profile I, Liu Yi, born in 1963, am a Chinese national with a Ph.D. in Economics. I am currently an independent director of the Company, a professor in the Department of Public Finance at the School of Economics, Peking University, and the Director of the China Institute for Tax and Public Finance Research at Peking University. I also serve as a non-executive director of China Taiping Insurance Group Co., Ltd. and China Taiping Insurance Group (Hong Kong) Limited.
(II) Statement on Independence As an independent director of the Company, I have strictly abided by laws, regulations, and the "Articles of Association." I have not held any positions in the Company other than independent director and member of the special committees of the Board of Directors. I have also not held any positions in the principal shareholders' entities. There are no relationships of interest with the Company or its principal shareholders, nor any other relationships that could hinder my independent and objective judgment. During the reporting period, my position complied with the independence requirements stipulated in the "Management Measures for Independent Directors of Listed Companies," and there were no circumstances affecting my independence.
II. 2025 Performance Review
(I) Attendance at Board and Shareholder Meetings In 2025, I devoted sufficient time to fulfilling my duties, personally attending 4 shareholder meetings and 11 board meetings. There were no instances of proxy attendance or absence from meetings. I actively fulfilled my obligations as an independent director. Before each board meeting, I carefully read and studied the proposals and exercised my voting rights prudently, safeguarding the overall interests of the Company and those of minority shareholders. Based on a thorough understanding of the situation, I raised no objections to the proposals reviewed at the 2025 meetings and voted in favor after careful consideration, with no dissenting or abstaining votes.
The convening and holding of the Company's board and shareholder meetings during this year complied with legal procedures. Major operational decisions and other significant matters were handled in accordance with relevant procedures, and were legal and effective.
(II) Performance in Special Committees of the Board of Directors As the Chairman of the Remuneration and Assessment Committee, a member of the Audit Committee, and a member of the Nomination Committee of the Eighth Board of Directors, I actively participated in meetings. My performance during the reporting period is as follows: